Literature DB >> 35059246

Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes.

Sachiko Otake1, Asako Sato2, Tetsuya Babazono1.   

Abstract

INTRODUCTION: Close association has been shown between diabetes and atrial fibrillation (AF). We conducted this single-center cross-sectional study to investigate the prevalence and predictors of AF in Japanese patients with type 2 diabetes. PATIENTS AND METHODS: Patients with type 2 diabetes were eligible if 12-lead electrocardiograms were recorded at the first visit between January 2004 and December 2005. The prevalence of AF in the patients was compared with that in the Japanese general population. Multivariate logistic regression analysis was conducted to determine the effect of independent variables on the prevalence of AF and non-valvular AF.
RESULTS: 1650 patients with type 2 diabetes, 588 women and 1,059 men, with the mean age of 60 ± 13 (SD) years were studied. Among them, 72 patients had AF, accounting for 4.4%, with a sex-specific prevalence of 2.5% in women and 5.4% in men. Of the 72 patients having AF, 12 patients had valvular AF and 60 patients had nonvalvular AF. When compared with the Japanese general population, the age- and sex-adjusted risk ratio for AF was 3.47 (95% confidence interval: 2.77-4.37). The prevalence of combined nonvalvular/valvular AF and nonvalvular AF increased with age. Other relevant factors associated with AF and nonvalvular AF were male sex, presence of hypertension, and decreased platelet count.
CONCLUSION: Higher prevalence of AF was observed in Japanese patients with type 2 diabetes than the general population. Advanced age, male sex, and hypertension were independent predictive factors for AF. © The Japan Diabetes Society 2021, corrected publication 2021.

Entities:  

Keywords:  Aging; Atrial fibrillation; Hypertension; Type 2 diabetes

Year:  2021        PMID: 35059246      PMCID: PMC8733104          DOI: 10.1007/s13340-021-00509-2

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  28 in total

1.  Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.

Authors:  Thomas A Zelniker; Marc P Bonaca; Remo H M Furtado; Ofri Mosenzon; Julia F Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Andrzej Budaj; Robert G Kiss; Francisco Padilla; Ingrid Gause-Nilsson; Anna Maria Langkilde; Itamar Raz; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2020-01-27       Impact factor: 29.690

2.  Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control?

Authors:  Francis E Ugowe; Larry R Jackson; Kevin L Thomas
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-05

3.  Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.

Authors:  Mia Vicki Fangel; Peter Brønnum Nielsen; Jette Kolding Kristensen; Torben Bjerregaard Larsen; Thure Filskov Overvad; Gregory Y H Lip; Martin Bach Jensen
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-05

Review 4.  Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.

Authors:  Allen Wang; Jennifer B Green; Jonathan L Halperin; Jonathan P Piccini
Journal:  J Am Coll Cardiol       Date:  2019-08-27       Impact factor: 24.094

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

Review 6.  Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients.

Authors:  S-I Yamagishi; T Matsui; K Nakamura
Journal:  Horm Metab Res       Date:  2008-09-15       Impact factor: 2.936

7.  Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city.

Authors:  Yasuyuki Iguchi; Kazumi Kimura; Junya Aoki; Kazuto Kobayashi; Yuka Terasawa; Kenichiro Sakai; Kensaku Shibazaki
Journal:  Circ J       Date:  2008-06       Impact factor: 2.993

Review 8.  Insulin resistance and hypertension in Japanese.

Authors:  O Iimura
Journal:  Hypertens Res       Date:  1996-06       Impact factor: 3.872

9.  High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.

Authors:  Stelios Karayiannides; Pia Lundman; Leif Friberg; Anna Norhammar
Journal:  Diab Vasc Dis Res       Date:  2017-10-20       Impact factor: 3.291

10.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.